Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane E Moore

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Chemical Communications (Cambridge, England)|July 31, 2008
Fluorous synthesis of allylic fluorides: C-F bond formation as the detagging processSophie Boldon, Jane E Moore, Véronique Gouverneur
Chemical Communications (Cambridge, England)|August 3, 2006
An alkynylboronic ester cycloaddition route to functionalised aromatic boronic estersPatrick M Delaney, Jane E Moore, Joseph P A Harrity
The Journal of Organic Chemistry|November 20, 2015
Synthesis of 4-Arylthieno[2,3-b]pyridines and 4-Aminothieno[2,3-b]pyridines via a Regioselective Bromination of Thieno[2,3-b]pyridineSimon C C Lucas, Jane E Moore, Craig S Donald, et al.
Organic & Biomolecular Chemistry|November 25, 2010
The traceless Staudinger ligation for indirect 18F-radiolabellingLaurence Carroll, Sophie Boldon, Romain Bejot, et al.
Journal of Medicinal Chemistry|April 5, 2017
Indazole-6-phenylcyclopropylcarboxylic Acids as Selective GPR120 Agonists with in Vivo EfficacyWilliam McCoull, Andrew Bailey, Peter Barton, et al.
Journal of Medicinal Chemistry|June 27, 2014
Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonistsWilliam McCoull, Peter Barton, Alastair J H Brown, et al.
Journal of Medicinal Chemistry|October 14, 2021
Discovery of a Series of 7-Azaindoles as Potent and Highly Selective CDK9 Inhibitors for Transient Target EngagementBernard Barlaam, Chris De Savi, Allan Dishington, et al.
ACS Medicinal Chemistry Letters|March 28, 2015
Pyrimidinone nicotinamide mimetics as selective tankyrase and wnt pathway inhibitors suitable for in vivo pharmacologyJeffrey W Johannes, Lynsie Almeida, Bernard Barlaam, et al.
Journal of Medicinal Chemistry|December 11, 2020
Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological MalignanciesBernard Barlaam, Robert Casella, Justin Cidado, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Chemical Communications (Cambridge, England)|July 31, 2008
Fluorous synthesis of allylic fluorides: C-F bond formation as the detagging processSophie Boldon, Jane E Moore, Véronique Gouverneur
Chemical Communications (Cambridge, England)|August 3, 2006
An alkynylboronic ester cycloaddition route to functionalised aromatic boronic estersPatrick M Delaney, Jane E Moore, Joseph P A Harrity
The Journal of Organic Chemistry|November 20, 2015
Synthesis of 4-Arylthieno[2,3-b]pyridines and 4-Aminothieno[2,3-b]pyridines via a Regioselective Bromination of Thieno[2,3-b]pyridineSimon C C Lucas, Jane E Moore, Craig S Donald, et al.
Organic & Biomolecular Chemistry|November 25, 2010
The traceless Staudinger ligation for indirect 18F-radiolabellingLaurence Carroll, Sophie Boldon, Romain Bejot, et al.
Journal of Medicinal Chemistry|April 5, 2017
Indazole-6-phenylcyclopropylcarboxylic Acids as Selective GPR120 Agonists with in Vivo EfficacyWilliam McCoull, Andrew Bailey, Peter Barton, et al.
Journal of Medicinal Chemistry|June 27, 2014
Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonistsWilliam McCoull, Peter Barton, Alastair J H Brown, et al.
Journal of Medicinal Chemistry|October 14, 2021
Discovery of a Series of 7-Azaindoles as Potent and Highly Selective CDK9 Inhibitors for Transient Target EngagementBernard Barlaam, Chris De Savi, Allan Dishington, et al.
ACS Medicinal Chemistry Letters|March 28, 2015
Pyrimidinone nicotinamide mimetics as selective tankyrase and wnt pathway inhibitors suitable for in vivo pharmacologyJeffrey W Johannes, Lynsie Almeida, Bernard Barlaam, et al.
Journal of Medicinal Chemistry|December 11, 2020
Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological MalignanciesBernard Barlaam, Robert Casella, Justin Cidado, et al.
Pageof 1